Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis

被引:12
|
作者
Tan, Shuai [1 ]
Xiao, Xiaojuan [2 ]
Ma, Hanyu [3 ]
Zhang, Zhaohui [4 ]
Chen, Jiangbo [5 ]
Ding, Lei [6 ]
Yu, Shenping [2 ]
Xu, Rulin [7 ]
Yang, Shiliang [1 ]
Huang, Xinyi [1 ]
Hong, Hua [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510080, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510080, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pancreatobiliary Surg, Guangzhou 510080, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Radiol, Guangzhou 510080, Guangdong, Peoples R China
[6] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou 510080, Guangdong, Peoples R China
[7] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510080, Guangdong, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 08期
关键词
TRANSIENT ISCHEMIC ATTACK; CEREBRAL INFARCTION; RECURRENCE; RISK; SURVIVAL;
D O I
10.1371/journal.pone.0135372
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Purpose Antiplatelet therapy is widely used for the primary or secondary prevention of stroke. Drugs like clopidogrel have emerged as alternatives for traditional antiplatelet therapy, and dual therapy with clopidogrel and aspirin is of particular interest. We conducted this meta-analysis to systematically review studies about dual therapy comparing monotherapy with aspirin alone. Methods Randomized controlled trials were searched in PubMed (1966-May, 2015), EMBASE (1947-May, 2015), the Cochrane Central Register of Controlled Trials (CENTRAL) (1948-May, 2015), WHO International Clinical Trial (ICTRP) (2004-May, 2015), China Biology Medicine disc (CBM disc) (1978-May, 2015) and were included into the final analysis according to the definite inclusion criteria mentioned in the study selection section. Risk ratio (RR) was pooled with 95% confidence interval (CI) for dichotomous data. The heterogeneity was considered significant if the chi(2) test was significant (P value < 0.10) or the I-2 > 50.00%. Subgroup analyses were carried out on the long and short time periods, the race and region. Results We included 5 studies involving 24,084 patients. A pooled analysis showed that dual therapy with clopidogrel and aspirin had a lower stroke incidence than monotherapy in both the short term and long term (RR = 0.69, 95% CI: 0.59-0.82, P <0.05; RR = 0.84, 95% CI: 0.72-0.98, P = 0.03, respectively). With regard to safety, dual therapy had a higher risk of bleeding than monotherapy for both periods (RR = 1.51, 95% CI: 1.03-2.23, P = 0.04; RR = 1.54, 95% CI: 1.32-1.79, P<0.05, respectively). Conclusions Dual therapy with clopidogrel and aspirin could be a preferable choice to prevent stroke in patients who have had a previous stroke or transient ischemic attack, as well as those who are at high risk for stroke. And the effect of dual therapy seems to be more obvious for short-term. However, it is associated with a higher risk of bleeding.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Aspirin and Clopidogrel for Prevention of Ischemic Stroke
    Thomson, Ruth M.
    Anderson, David C.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (02)
  • [22] Clopidogrel plus aspirin for stroke prevention
    Alberts, MJ
    Easton, JD
    STROKE, 2002, 33 (11) : 2546 - 2547
  • [23] Efficacy and safety of aspirin plus clopidogrel versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: A meta-analysis of randomized controlled trials
    Ahmed, Mushood
    Ahsan, Areeba
    Fatima, Laveeza
    Basit, Jawad
    Nashwan, Abdulqadir J.
    Ali, Shafaqat
    Hamza, Mohammad
    Karalis, Iosif
    Ahmed, Raheel
    Alareed, Ahmad
    Ijioma, Nkechinyere N.
    Alraies, M. Chadi
    VASCULAR MEDICINE, 2024, 29 (05) : 517 - 525
  • [24] Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation An indirect comparison analysis
    Blann, Andrew D.
    Skjoth, Flemming
    Rasmussen, Lars H.
    Larsen, Torben B.
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (02) : 403 - 409
  • [25] Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke Clopidogrel Plus Aspirin Versus Aspirin Alone
    Hong, Keun-Sik
    Lee, Seung-Hoon
    Kim, Eung Gyu
    Cho, Ki-Hyun
    Chang, Dae Il
    Rha, Joung-Ho
    Bae, Hee-Joon
    Lee, Kyung Bok
    Kim, Dong Eog
    Park, Jong-Moo
    Kim, Hahn-Young
    Cha, Jae-Kwan
    Yu, Kyung-Ho
    Lee, Yong-Seok
    Lee, Soo Joo
    Choi, Jay Chol
    Cho, Yong-Jin
    Kwon, Sun U.
    Kim, Gyeong-Moon
    Sohn, Sung-Il
    Park, Kwang-Yeol
    Kang, Dong-Wha
    Sohn, Chul-Ho
    Lee, Jun
    Yoon, Byung-Woo
    STROKE, 2016, 47 (09) : 2323 - 2330
  • [26] COST-EFFECTIVENESS OF CLOPIDOGREL-ASPIRIN VERSUS ASPIRIN ALONE FOR ACUTE TIA AND MINOR STROKE
    Pan, Y.
    Wang, Y. L.
    Liu, G.
    Zhao, K.
    Wang, Y.
    VALUE IN HEALTH, 2014, 17 (07) : A760 - A760
  • [27] Meta-analysis of heparin combined with aspirin versus aspirin alone for unexplained recurrent spontaneous abortion
    Li, Jie
    Gao, Yue-hua
    Xu, Lin
    Li, Zeng-yan
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2020, 151 (01) : 23 - 32
  • [28] Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone
    Rothberg, M
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (06) : 464 - 464
  • [29] Aspirin plus clopidogrel versus aspirin mono-therapy for ischemic stroke: a meta-analysis (vol 53, pg 169, 2020)
    Ye, Mao-Bin
    Chen, Yan-Lin
    Wang, Qin
    An, Jun
    Ye, Fei
    Jing, Ping
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2020, 54 (02) : 138 - 138
  • [30] Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease
    Keller, T. T.
    Squizzato, A.
    Middeldorp, S.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (03):